Clinical Trials Directory

Trials / Unknown

UnknownNCT04562402

Phaco-ECP vs Phaco Alone in Primary Angle Closure

Phacoemulsification With Endoscopic Cyclophotocoagulation vs Phacoemulsification Alone in Primary Angle Closure (PHEPHA): A Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
King Khaled Eye Specialist Hospital · Other Government
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Comparison between phacoemulsification with endoscopic cyclophotocoagulation versus phacoemulsification alone in patients with either primary angle closure or primary angle closure glaucoma presenting with cataract or a clear lens.

Detailed description

The purpose of our current randomized clinical trial is to compare phacoemulsification with endoscopic cyclophotocoagulation (PHE) versus phacoemulsification alone (PHA) in patients with either primary angle closure (PAC) or primary angle closure glaucoma (PACG) presenting with cataract or a clear lens.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhacoemulsificationcataract surgery via phacoemulsification
PROCEDUREEndoscopic cyclophotocoagulationEndoscopic ablation of the ciliary body

Timeline

Start date
2020-08-16
Primary completion
2022-02-15
Completion
2022-02-15
First posted
2020-09-24
Last updated
2020-09-24

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT04562402. Inclusion in this directory is not an endorsement.